APOGENIX AG has a total of 106 patent applications. It increased the IP activity by 150.0%. Its first patent ever was published in 2008. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are Ichnos Sciences SA, AFFITECH AS and TRUBION PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 27 | |
#2 | EPO (European Patent Office) | 23 | |
#3 | Australia | 12 | |
#4 | Canada | 10 | |
#5 | WIPO (World Intellectual Property Organization) | 9 | |
#6 | China | 6 | |
#7 | Mexico | 4 | |
#8 | Japan | 3 | |
#9 | Ukraine | 2 | |
#10 | Brazil | 1 | |
#11 | Costa Rica | 1 | |
#12 | Ecuador | 1 | |
#13 | Hungary | 1 | |
#14 | Israel | 1 | |
#15 | Republic of Korea | 1 | |
#16 | New Zealand | 1 | |
#17 | Peru | 1 | |
#18 | Russian Federation | 1 | |
#19 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Gieffers Christian | 86 |
#2 | Hill Oliver | 83 |
#3 | Thiemann Meinolf | 83 |
#4 | Schnyder Tim | 51 |
#5 | Fricke Harald | 20 |
#6 | Sykora Jaromir | 11 |
#7 | Merz Christian | 8 |
#8 | Kunz Claudia | 8 |
#9 | Fontenay Michaela | 7 |
#10 | Christian Gieffers | 7 |
Publication | Filing date | Title |
---|---|---|
EP3365448A1 | Single-chain cd137-receptor agonist proteins | |
WO2017068185A1 | Single-chain gitr-receptor agonist proteins | |
CA3002587A1 | Single-chain light receptor agonist proteins | |
AU2016341409A1 | Single-chain CD27-receptor agonist proteins | |
CA3002600A1 | Single-chain ox40-receptor agonist proteins | |
EP3368558A1 | Single-chain tl1a receptor agonist proteins | |
AU2016325482A1 | Anti-CD95L antibody | |
JP2016210791A | Fusion proteins forming trimers | |
WO2017009429A1 | Method of predicting the responsiveness of a cancer disease to treatment | |
BR112017023646A2 | single chain cd40 receptor agonist proteins | |
EP3094744A1 | Method of predicting the responsiveness of a cancer disease to treatment on the basis of dna methylation | |
SI2874659T1 | Inhibitors of the cd95 signaling pathway for treatment of mds | |
AU2013203061A1 | TNF superfamily collectin fusion proteins | |
EP2382236A1 | Fusion proteins forming trimers |